Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Adam

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer CellsVeronica Calvo, Wei Zheng, Anna Adam-Artigues, et al.
Science Advances|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancerAnna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Research Square|December 9, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer CellsVeronica Calvo, Wei Zheng, Anna Adam-Artigues, et al.
Science Advances|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancerAnna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Research Square|December 9, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Pageof 3